返回
Viral gastroenteritis
DOI:10.1016/S0140-6736(23)02037-8.png)
摘要
En 中文
Since the discovery of norovirus in 1972 as a cause of what was contemporarily known as acute infectious nonbacterial gastroenteritis, scientific understanding of the viral gastroenteritides has continued to evolve. It is now recognised that a small number of viruses are the predominant cause of acute gastroenteritis worldwide, in both high-income and low-income settings. Although treatment is still largely restricted to the replacement of fluid and electrolytes, improved diagnostics have allowed attribution of illness, enabling both targeted treatment of individual patients and prioritisation of interventions for populations worldwide. Questions remain regarding specific genetic and immunological factors underlying host susceptibility, and the optimal clinical management of patients who are susceptible to severe or prolonged manifestations of disease. Meanwhile, the worldwide implementation of rotavirus vaccines has led to substantial reductions in morbidity and mortality, and spurred interest in vaccine development to diminish the impact of the most prevalent viruses that are implicated in this syndrome.
Keyword:
HUMAN ROTAVIRUS VACCINE
HUMAN INTESTINAL ENTEROIDS
NOROVIRUS INFECTION
DOUBLE-BLIND
ADENOVIRUS INFECTIONS
BIRTH COHORT
RISK-FACTOR
CHILDREN
DIARRHEA
DISEASE
期刊
IF:
88.5
论文数:
5.4W
被引数:
34.8W
机构
引用论文
Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study可注射的下一代轮状病毒疫苗在137 lmic中的潜在影响和成本效益: 一项建模研究
Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial
LANCET
IF88.5
Human adenovirus infections in pediatric population - An update on clinico-pathologic correlation儿科人群中的人类腺病毒感染——临床病理相关性的最新进展
BIOMEDICAL JOURNAL
IF4.4

